176 related articles for article (PubMed ID: 1425834)
1. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry.
Saracino GA; Ditonno P; Disabato G; Traficante A; Battaglia M; Lucivero G; Selvaggi FP
Eur Urol; 1992; 21 Suppl 1():26-30. PubMed ID: 1425834
[TBL] [Abstract][Full Text] [Related]
2. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
3. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
6. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
Maier G; Heissler HE; Blech M; Schröter W
Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
[TBL] [Abstract][Full Text] [Related]
7. [Proliferative activity assessed on the basis of DNA ploidy patterns in primary lung cancer].
Yamaoka N; Tagawa Y; Miyashita K; Ayabe H; Kawahara K; Uchiyama Y; Tomita M
Nihon Geka Gakkai Zasshi; 1991 May; 92(5):598-602. PubMed ID: 1875901
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy.
Hug EB; Donnelly SM; Shipley WU; Heney NM; Kaufman DS; Preffer FI; Schwartz SM; Colvin RB; Althausen AF
J Urol; 1992 Jul; 148(1):47-51. PubMed ID: 1613879
[TBL] [Abstract][Full Text] [Related]
9. DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.
Gustafson H; Tribukait B; Esposti PL
Scand J Urol Nephrol; 1982; 16(2):135-9. PubMed ID: 7123163
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA/cytokeratin analysis of bladder lavage: methodical aspects and clinical implications.
Liedl T
Urol Int; 1995; 54(1):22-47. PubMed ID: 7770998
[TBL] [Abstract][Full Text] [Related]
11. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
13. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of flow cytometry in superficial bladder cancer.
Di Silverio F; von Heland M; De Berardinis E; Izzi R; Buscarini M; De Vita R; Forte R; Seccareccia F; Menotti A
Eur Urol; 1992; 21 Suppl 1():22-5. PubMed ID: 1425833
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
[TBL] [Abstract][Full Text] [Related]
16. P53 and ploidy assessed by flow cytometry in bladder washings.
Griffiths TR; Mellon JK; Pyle GA; Shenton BK; Neal DE
Br J Urol; 1995 Nov; 76(5):575-9. PubMed ID: 8535675
[TBL] [Abstract][Full Text] [Related]
17. Characterization of squamous cell bladder tumors by flow cytometric deoxyribonucleic acid analysis: a report of 100 cases.
Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA
J Urol; 1990 Oct; 144(4):879-83. PubMed ID: 2398562
[TBL] [Abstract][Full Text] [Related]
18. Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial.
Bruno S; Torrisi R; Costantini M; Baglietto L; Fontana V; Gatteschi B; Melioli G; Nicolo G; Curotto A; Malcangi B; Bruttini GP; Varaldo M; Bruzzi P; Decensi A
J Cell Biochem; 1999 Dec; 76(2):311-21. PubMed ID: 10618647
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
Sun X
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer.
Têtu B; Allard P; Fradet Y; Roberge N; Bernard P
Hum Pathol; 1996 Sep; 27(9):922-6. PubMed ID: 8816887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
